Your browser doesn't support javascript.
loading
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge.
Gary, Ebony N; Tursi, Nicholas J; Warner, Bryce M; Cuismano, Gina; Connors, Jennifer; Parzych, Elizabeth M; Griffin, Bryan D; Bell, Matthew R; Ali, Ali R; Frase, Drew; Hojecki, Casey E; Canziani, Gabriela A; Chaiken, Irwin; Kannan, Toshitha; Moffat, Estella; Embury-Hyatt, Carissa; Wooton, Sarah K; Kossenkov, Andrew; Patel, Ami; Kobasa, Darwyn; Kutzler, Michele A; Haddad, Elias K; Weiner, David B.
Afiliação
  • Gary EN; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Tursi NJ; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Warner BM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Cuismano G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Connors J; The Department of Medicine, Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Parzych EM; The Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Griffin BD; The Department of Medicine, Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Bell MR; The Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Ali AR; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Frase D; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Hojecki CE; The Department of Medicine, Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Canziani GA; The Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Chaiken I; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Kannan T; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Moffat E; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Embury-Hyatt C; The Department of Biochemistry, Drexel University college of Medicine, Philadelphia, PA, United States.
  • Wooton SK; The Department of Biochemistry, Drexel University college of Medicine, Philadelphia, PA, United States.
  • Kossenkov A; The Genomics Core, The Wistar Institute, Philadelphia, PA, United States.
  • Patel A; National Center for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB, Canada.
  • Kobasa D; National Center for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB, Canada.
  • Kutzler MA; Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
  • Haddad EK; The Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States.
  • Weiner DB; The Genomics Core, The Wistar Institute, Philadelphia, PA, United States.
Front Immunol ; 14: 1138609, 2023.
Article em En | MEDLINE | ID: mdl-36999023
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça